Volume 2, Issue 2 (9-2016)
CJP 2016, 2(2): 0 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Sorkhi H, Alijanpour M, Sadr Moharrerpour S. Tacrolimus and diabetic ketoacidosis after kidney transplantation in a 15-year-old girl (Case Report). CJP 2016; 2 (2) :171-174
URL: http://caspianjp.ir/article-1-59-en.html
URL: http://caspianjp.ir/article-1-59-en.html
Non-Communicable Pediatric Diseases Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, IR Iran. , hadisorkhi@yahoo.com
Abstract: (6802 Views)
Tacrolimus is a main drug for induction and maintenance immunosuppression for patients with kidney transplants in many centers. One of important side effect of drug is post-transplant diabetes mellitus. Of course, diabetes ketoacidosis (DKA) is rare. In this report, a 12-year-old girl with DKA was presented after 45 days of kidney transplantation.
Type of Study: case report |
Subject:
Special
Send email to the article author
| Rights and Permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
